Form D · Biotechnology

NovAb, Inc.

Tucker, GA · CIK 0001685163

Offering snapshot reported Apr 16, 2026 · SEC filing

Reported sold
$65K
Offering amount: $250K
Investors reported
2
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Apr 1, 2026
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Apr 16, 2026Initial$65,000No comparison2SEC filing
Jan 26, 2026Initial$50,000No comparison2SEC filing
Aug 12, 2025Initial$210,000No comparison2SEC filing
Feb 11, 2025Initial$250,000No comparison3SEC filing
Jul 12, 2024Initial$125,000No comparison2SEC filing
Aug 11, 2023Initial$250,000No comparison3SEC filing
Mar 9, 2023Initial$300,000No comparison3SEC filing
Mar 16, 2022Initial$300,000No comparison5SEC filing
Sep 30, 2016InitialYet to sellNo comparison0SEC filing

Offering details

Securities
Debt, Other
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-580693
Convertible notes

Source: Form D, filed Apr 16, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
L. Edward Cannon Director, Executive
Lovick Edward Cannon Director, Executive
Thomas Chris Cannon Director
Max D. Cooper Director
Greg Dane Director
Gregory Dane Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
1860 Montreal Road
Tucker, GA, 30084